Superoxide dismutase, quantified by an enzyme immunoassay, is an biochemical marker for the prenatal and postnatal diagnosis of trisomy 21. The method is used in the Charite beside karyotyping for this purpose. A case of fetal triploidy is described in this paper, which has also been detected by the same method.